XMTR Quote, Financials, Valuation and Earnings

LegalZoom.com has a net margin of -7.2% compared to Xometry's net margin of 6.56%. Xometry's return on equity of -15.74% beat LegalZoom.com's return on equity of 20.24%.

Xometry has a consensus price target of $33.70, signalling downside risk potential of -19.17%. On the other hand LegalZoom.com has an analysts' consensus of -- which suggests that it could grow by 5.17%. Given that LegalZoom.com has higher upside potential than Xometry, analysts believe LegalZoom.com is more attractive than Xometry.

Xometry has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison LegalZoom.com has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Xometry has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. LegalZoom.com offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Xometry pays -- of its earnings as a dividend. LegalZoom.com pays out -- of its earnings as a dividend.

Xometry quarterly revenues are $141.7M, which are smaller than LegalZoom.com quarterly revenues of $168.6M. Xometry's net income of -$10.2M is lower than LegalZoom.com's net income of $11.1M. Notably, Xometry's price-to-earnings ratio is -- while LegalZoom.com's PE ratio is 59.77x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Xometry is 3.87x versus 2.14x for LegalZoom.com. Usually stocks with elevated PS ratios are considered overvalued.

Rosinbomb has a net margin of -7.2% compared to Xometry's net margin of --. Xometry's return on equity of -15.74% beat Rosinbomb's return on equity of --.

Xometry has a consensus price target of $33.70, signalling downside risk potential of -19.17%. On the other hand Rosinbomb has an analysts' consensus of -- which suggests that it could fall by --. Given that Xometry has higher upside potential than Rosinbomb, analysts believe Xometry is more attractive than Rosinbomb.

Xometry has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Rosinbomb has a beta of 1.442, suggesting its more volatile than the S&P 500 by 44.222%.

Xometry has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Rosinbomb offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Xometry pays -- of its earnings as a dividend. Rosinbomb pays out -- of its earnings as a dividend.

Xometry quarterly revenues are $141.7M, which are larger than Rosinbomb quarterly revenues of --. Xometry's net income of -$10.2M is higher than Rosinbomb's net income of --. Notably, Xometry's price-to-earnings ratio is -- while Rosinbomb's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Xometry is 3.87x versus -- for Rosinbomb. Usually stocks with elevated PS ratios are considered overvalued.

Team has a net margin of -7.2% compared to Xometry's net margin of -5.28%. Xometry's return on equity of -15.74% beat Team's return on equity of -152.04%.

Xometry has a consensus price target of $33.70, signalling downside risk potential of -19.17%. On the other hand Team has an analysts' consensus of -- which suggests that it could grow by 771.31%. Given that Team has higher upside potential than Xometry, analysts believe Team is more attractive than Xometry.

Xometry has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Team has a beta of 1.785, suggesting its more volatile than the S&P 500 by 78.464%.

Xometry has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Team offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Xometry pays -- of its earnings as a dividend. Team pays out -- of its earnings as a dividend.

Xometry quarterly revenues are $141.7M, which are smaller than Team quarterly revenues of $210.8M. Xometry's net income of -$10.2M is higher than Team's net income of -$11.1M. Notably, Xometry's price-to-earnings ratio is -- while Team's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Xometry is 3.87x versus 0.08x for Team. Usually stocks with elevated PS ratios are considered overvalued.

Verra Mobility has a net margin of -7.2% compared to Xometry's net margin of 15.4%. Xometry's return on equity of -15.74% beat Verra Mobility's return on equity of 22.99%.

Xometry has a consensus price target of $33.70, signalling downside risk potential of -19.17%. On the other hand Verra Mobility has an analysts' consensus of -- which suggests that it could grow by 23.93%. Given that Verra Mobility has higher upside potential than Xometry, analysts believe Verra Mobility is more attractive than Xometry.

Xometry has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Verra Mobility has a beta of 1.229, suggesting its more volatile than the S&P 500 by 22.947%.

Xometry has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Verra Mobility offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Xometry pays -- of its earnings as a dividend. Verra Mobility pays out -- of its earnings as a dividend.

Xometry quarterly revenues are $141.7M, which are smaller than Verra Mobility quarterly revenues of $225.6M. Xometry's net income of -$10.2M is lower than Verra Mobility's net income of $34.7M. Notably, Xometry's price-to-earnings ratio is -- while Verra Mobility's PE ratio is 40.12x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Xometry is 3.87x versus 4.59x for Verra Mobility. Usually stocks with elevated PS ratios are considered overvalued.